Cybin is trading at $13.78, up +5.80%, after the biotechnology sector gained 2.06% during the regular session.
- No fresh company-specific announcement or earnings catalyst was identified for August 25, 2026.
- Recent coverage highlights the earlier CEO appointment and Phase 3 progress.
- Broader markets are modestly higher, while live-market trading continued at 10:33 AM EST.